Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind active-controlled trial of a CHO cell-derived recombinant herpes zoster vaccine in adults aged 40 years and older
CTR20252721Phase 2Active
- Sponsor
- Grand Sevaxin
- Start
- Jul 2025
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant herpes zoster vaccine (CHO cells) in herpes zoster (HZ), sponsored by Grand Sevaxin. Started Jul 2025; status: active.
02
Drugs
recombinant herpes zoster vaccine (CHO cells)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20252721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252721.